Geode Capital Management, LLC Kiora Pharmaceuticals Inc Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$0.36 - $0.68 $6,251 - $11,807
17,364 Added 3.28%
547,128 $257,000
Q1 2022

May 13, 2022
BUY
$0.54 - $1.27 $3,137 - $7,378
5,810 Added 1.11%
529,764 $329,000
Q4 2021

Feb 11, 2022
BUY
$0.86 - $2.11 $450,600 - $1.11 Million
523,954 New
523,954 $791,000

About KIORA PHARMACEUTICALS INC

KPRX Quotes by TradingView
  • Ticker KPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 919,078
  • Market Cap $3.02M
  • Description
  • Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients ...
More about KPRX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email